<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cue Biopharma, Inc. (CUE) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/cue/filings</link>
    <description>Latest company filings for Cue Biopharma, Inc. (CUE) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Mon, 13 Jul 2026 00:18:22 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/cue/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[CUE: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526233369/d38874ddef14a.htm</link>
      <guid isPermaLink="false">0001193125-26-233369</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Proxy statement (DEF 14A) on 2026-05-21.]]></description>
      <pubDate>Thu, 21 May 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[CUE: D]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000164546026000003/xslFormDX01/primary_doc.xml</link>
      <guid isPermaLink="false">0001645460-26-000003</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a D (D) on 2026-05-14.]]></description>
      <pubDate>Thu, 14 May 2026 12:00:00 GMT</pubDate>
      <category>D</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526224101/cue-20260514.htm</link>
      <guid isPermaLink="false">0001193125-26-224101</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2026-05-14.]]></description>
      <pubDate>Thu, 14 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526224091/cue-20260331.htm</link>
      <guid isPermaLink="false">0001193125-26-224091</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Quarterly report (10-Q) on 2026-05-14.]]></description>
      <pubDate>Thu, 14 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[CUE: PRE 14A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526217130/d38874dpre14a.htm</link>
      <guid isPermaLink="false">0001193125-26-217130</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a PRE 14A (PRE 14A) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>PRE 14A</category>
    </item>
    <item>
      <title><![CDATA[CUE: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526211809/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-211809</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a New insider ownership (3) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526211806/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-211806</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526198622/d100051ds8.htm</link>
      <guid isPermaLink="false">0001193125-26-198622</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Employee stock plan (S-8) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526198588/d128047d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-198588</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526168907/cue-20260422.htm</link>
      <guid isPermaLink="false">0001193125-26-168907</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2026-04-22.]]></description>
      <pubDate>Wed, 22 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526152826/cue-20260413.htm</link>
      <guid isPermaLink="false">0001193125-26-152826</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2026-04-13.]]></description>
      <pubDate>Mon, 13 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526151202/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-151202</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526151201/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-151201</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526151200/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-151200</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526144569/cue-20260401.htm</link>
      <guid isPermaLink="false">0001193125-26-144569</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2026-04-07.]]></description>
      <pubDate>Tue, 07 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/999999999526001020/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-26-001020</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a EFFECT (EFFECT) on 2026-03-31.]]></description>
      <pubDate>Tue, 31 Mar 2026 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[CUE: Company correspondence (CORRESP)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526129018/filename1.htm</link>
      <guid isPermaLink="false">0001193125-26-129018</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Company correspondence (CORRESP) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>CORRESP</category>
    </item>
    <item>
      <title><![CDATA[CUE: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526129007/d107324ddefa14a.htm</link>
      <guid isPermaLink="false">0001193125-26-129007</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Proxy materials (DEFA14A) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526128993/d120770d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-128993</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: SEC correspondence (UPLOAD)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000000000026002905/filename1.pdf</link>
      <guid isPermaLink="false">0000000000-26-002905</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a SEC correspondence (UPLOAD) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>UPLOAD</category>
    </item>
    <item>
      <title><![CDATA[CUE: Securities registration (S-3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526108656/d87688ds3.htm</link>
      <guid isPermaLink="false">0001193125-26-108656</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Securities registration (S-3) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>S-3</category>
    </item>
    <item>
      <title><![CDATA[CUE: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526108307/ars_-_2026_proxy.pdf</link>
      <guid isPermaLink="false">0001193125-26-108307</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Annual report to shareholders (ARS) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[CUE: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm</link>
      <guid isPermaLink="false">0001193125-26-108301</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Proxy statement (DEF 14A) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526108292/cue-20260316.htm</link>
      <guid isPermaLink="false">0001193125-26-108292</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526108287/cue-20251231.htm</link>
      <guid isPermaLink="false">0001193125-26-108287</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Annual report (10-K) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: PRE 14A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526096441/cue-20260306.htm</link>
      <guid isPermaLink="false">0001193125-26-096441</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a PRE 14A (PRE 14A) on 2026-03-06.]]></description>
      <pubDate>Fri, 06 Mar 2026 12:00:00 GMT</pubDate>
      <category>PRE 14A</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526056983/cue-20260218.htm</link>
      <guid isPermaLink="false">0001193125-26-056983</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2026-02-18.]]></description>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526047717/cue-20260209.htm</link>
      <guid isPermaLink="false">0001193125-26-047717</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2026-02-12.]]></description>
      <pubDate>Thu, 12 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526004359/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-004359</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2026-01-06.]]></description>
      <pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526004358/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-004358</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2026-01-06.]]></description>
      <pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526004357/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-004357</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2026-01-06.]]></description>
      <pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526004356/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-004356</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2026-01-06.]]></description>
      <pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526004355/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-004355</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2026-01-06.]]></description>
      <pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526004354/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-004354</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2026-01-06.]]></description>
      <pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312526000900/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-000900</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2026-01-02.]]></description>
      <pubDate>Fri, 02 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000195004725010720/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-25-010720</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider sale notice (144) on 2025-12-29.]]></description>
      <pubDate>Mon, 29 Dec 2025 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312525326925/d213128d8k.htm</link>
      <guid isPermaLink="false">0001193125-25-326925</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2025-12-19.]]></description>
      <pubDate>Fri, 19 Dec 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312525326847/d79932d424b5.htm</link>
      <guid isPermaLink="false">0001193125-25-326847</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Prospectus supplement (424B5) on 2025-12-19.]]></description>
      <pubDate>Fri, 19 Dec 2025 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[CUE: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312525324820/d79932d424b5.htm</link>
      <guid isPermaLink="false">0001193125-25-324820</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Prospectus supplement (424B5) on 2025-12-18.]]></description>
      <pubDate>Thu, 18 Dec 2025 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312525310067/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-310067</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2025-12-05.]]></description>
      <pubDate>Fri, 05 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312525296986/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-296986</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2025-11-25.]]></description>
      <pubDate>Tue, 25 Nov 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312525296985/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-296985</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2025-11-25.]]></description>
      <pubDate>Tue, 25 Nov 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312525292093/cue-20251124.htm</link>
      <guid isPermaLink="false">0001193125-25-292093</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2025-11-24.]]></description>
      <pubDate>Mon, 24 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312525289713/cue-20251117.htm</link>
      <guid isPermaLink="false">0001193125-25-289713</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2025-11-20.]]></description>
      <pubDate>Thu, 20 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312525277468/cue-20251112.htm</link>
      <guid isPermaLink="false">0001193125-25-277468</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2025-11-12.]]></description>
      <pubDate>Wed, 12 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312525277466/cue-20250930.htm</link>
      <guid isPermaLink="false">0001193125-25-277466</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Quarterly report (10-Q) on 2025-11-12.]]></description>
      <pubDate>Wed, 12 Nov 2025 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312525268135/cue-20251106.htm</link>
      <guid isPermaLink="false">0001193125-25-268135</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2025-11-06.]]></description>
      <pubDate>Thu, 06 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[CUE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312525228920/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-228920</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Insider trade (4) on 2025-10-02.]]></description>
      <pubDate>Thu, 02 Oct 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[CUE: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000119312525228919/xslF345X02/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-228919</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a New insider ownership (3) on 2025-10-02.]]></description>
      <pubDate>Thu, 02 Oct 2025 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[CUE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1645460/000095013025000140/cue-20250926.htm</link>
      <guid isPermaLink="false">0000950130-25-000140</guid>
      <description><![CDATA[Cue Biopharma, Inc. filed a Major company event (8-K) on 2025-09-29.]]></description>
      <pubDate>Mon, 29 Sep 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
  </channel>
</rss>